ADVFN US – Market Content Editor
-

Chip Sell-Off Drags Nasdaq, Dow Edges Higher
U.S. stocks finished a volatile week on a mixed note Friday, as a renewed sell-off in semiconductor shares pulled the tech-heavy Nasdaq lower while the Dow managed a small gain. Investors continued to digest the fallout from Jensen Huang’s resignation as Nvidia’s CEO, along with a wholesale inflation report that reinforced expectations the Federal Reserve…
-

Heliostar Presents Q3 2026 Financial and Operating Results with Record Mine Operating Earnings and Cash Balance
Q3 2026 Highlights: Vancouver, Canada – Heliostar Metals Ltd. (TSX: HSTR, OTCQX: HSTXF, FRA: RGG1) (“Heliostar” or the “Company”) reported unaudited financial results for the three and nine months ended September 30, 2026 (“Q3”). Results are presented in US dollars, unless otherwise stated. Heliostar Metals Ltd. is a B2i Digital New and Notable company. Its…
-

Equity Metals Advances Silver Queen Towards 2027 PEA as Arlington Emerges as Second Growth Opportunity
Equity Metals Corporation (TSX-V:EQTY) (USOTC:EQMEF) (FSE:EGSD) is continuing to build the foundations for future development at its Silver Queen silver-gold project in British Columbia, with further resource validation work underway and a Preliminary Economic Assessment (PEA) targeted for Q2 2027. Alongside this progress, exploration at the Arlington property is identifying new targets that could provide…
-

VirTra Reports 42% Third-Quarter Revenue Growth to $7.6 Million as Bookings Reach $10.3 Million
VirTra, Inc. (NASDAQ:VTSI), a provider of firearms and use-of-force training simulators, reported a 42% increase in third-quarter 2026 revenue to $7.6 million, compared with $5.3 million in the corresponding period last year, supported by higher government and international sales. The company returned to quarterly profitability, reporting net income of $2.2 million, or $0.19 per diluted…
-

Rezolute Reports Phase 3 upLIFT Study Meets Primary Efficacy Endpoint in Tumor Hyperinsulinism
Rezolute, Inc. (NASDAQ:RZLT), a clinical-stage biotechnology company developing treatments for rare metabolic diseases, announced that its ongoing Phase 3 upLIFT study of ersodetug in patients with tumor hyperinsulinism has met its primary efficacy endpoint, based on preliminary data evaluated on November 5, 2026. The open-label study is assessing ersodetug in patients experiencing uncontrolled hypoglycemia associated…
-

Zhibao Technology Reports 16% Revenue Growth to RMB 319.9 Million and Narrows Annual Net Loss by 95.3%
Zhibao Technology Inc. (NASDAQ:ZBAO), a China-based digital insurance brokerage provider, reported a 16% increase in revenue to RMB 319.9 million (US$47.1 million) for the fiscal year ended June 30, 2026, compared with RMB 276.9 million in the previous year. The company, which filed its annual report on Form 20-F with the US Securities and Exchange…
-

Onfolio Holdings Reports Stockholders’ Equity Above Nasdaq Minimum and No Outstanding Convertible Notes
Onfolio Holdings, Inc. (NASDAQ:ONFO), an operator and acquirer of online businesses, announced that its stockholders’ equity has risen above the $2.5 million minimum required for continued listing on the Nasdaq Capital Market, as the company continues efforts to address its balance sheet and listing requirements. Nasdaq granted Onfolio an extension in October until November 23,…
-

Digi Power X Reports 85% Quarterly Revenue Growth to $12.25 Million as AI Revenue Exceeds $5.6 Million
Digi Power X Inc. (NASDAQ:DGXX), an artificial intelligence data center infrastructure operator, reported an 85% increase in third-quarter 2026 revenue to $12.25 million, compared with $6.63 million in the preceding quarter. Revenue rose 50% from $8.1 million in the same period last year. For the quarter ended September 30, 2026, AI-related revenue increased by more…
-

Nexera Technologies Subsidiary Fort Technology Secures Financing Agreements for Up to $20 Million
Nexera Technologies Ltd (NASDAQ:NEXR) announced that its subsidiary Fort Technology Inc. (NASDAQ:FRTT) has entered into securities purchase agreements with two institutional investors for potential financing of up to $20 million to support working capital, e-commerce operations and data center-related activities. Under the agreements, Fort may issue unsecured convertible promissory notes with an aggregate principal amount…
